However, the effect of mdivi-1 appears to be time- and dose-dependent because complete or long-term inhibition of Drp1 causes harmful effects in diabetic cardiomyopathy and cardiac hypertrophy by promoting the accumulation of damaged mitochondria and impairing cardiac function [73,139,148]. This evidence concerns the gene DNM1L and cardiac hypertrophy.